Eliem Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELYM and other ETFs, options, and stocks.

About ELYM

Eliem Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems. 

CEO
Andrew D. Levin
CEOAndrew D. Levin
Employees
9
Employees9
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
2018
Founded2018
Employees
9
Employees9

ELYM Key Statistics

Market cap
280.29M
Market cap280.29M
Price-Earnings ratio
-7.73
Price-Earnings ratio-7.73
Dividend yield
Dividend yield
Average volume
965.88K
Average volume965.88K
High today
$11.53
High today$11.53
Low today
$8.02
Low today$8.02
Open price
$8.40
Open price$8.40
Volume
1.48M
Volume1.48M
52 Week high
$11.55
52 Week high$11.55
52 Week low
$2.34
52 Week low$2.34
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.